Loyalty Juggernaut Receives US Patent for Innovative Technology Enabling Individualized Experiences at Scale – PR Newswire
Loyalty Juggernaut Receives US Patent for Innovative Technology Enabling Individualized Experiences at Scale PR Newswire
Archive for May, 2024
-
In: PATENT NEWS
-
In: PATENT NEWS
Example clauses for Patent Markings – AllDrafts
Patent Markings contract clause examples. … patent notices or markings on the Product itself or on such … law) of the country of manufacture, use or …
-
In: PATENT NEWS
USPTO Issues Notice of Proposes Rulemaking for New 2025 Fees
US Patent and Trademark Office USPTO publishes Notice of Proposed … Brinckerhoff, intellectual property law attorney, Foley & Lardner Law Firm.
-
In: PATENT NEWS
Bipartisan Focus on Drug Prices Continues with Proposed Expansion of Federal Authority …
… patent rights. By marching in, the US government would grant a license to a patent covered by the Bayh-Dole Act to a third party to manufacture …
-
In: PATENT NEWS
Senate Releases Bipartisan AI Roadmap | Insights – Holland & Knight
… intellectual property law and take appropriate action to preserve U.S. leadership; consider legislation to create a national AI literacy campaign …
-
In: COPYRIGHT NEWS
How copyright is killing creativity — except Taylor Swift’s – The Hill
How copyright is killing creativity — except Taylor Swift’s The Hill
-
In: PATENT NEWS
Moderna Fends Off Pfizer’s MRNA Patent Challenge – Law360
“We will continue to pursue and enforce patent rights covering our innovative technology.” This is the latest development in the ongoing patent …
-
In: PATENT NEWS
Moderna Fends Off Pfizer’s MRNA Patent Challenge – Law360
Moderna Fends Off Pfizer’s MRNA Patent Challenge Law360
-
In: PATENT NEWS
Bipartisan Focus on Drug Prices Continues with Proposed Expansion of Federal Authority Over Patent Rights – JD Supra
Bipartisan Focus on Drug Prices Continues with Proposed Expansion of Federal Authority Over Patent Rights JD Supra
-
In: PATENT NEWS
Senate’s new controversial patent reform target – Axios
Friction point: Advocacy groups like Families USA, Patients for Affordable Drugs and Public Citizen have all spoken out against the PREVAIL Act.